Allelic Variants
|
There are no related allelic variants
|
|
Number of involved diseases in the family |
50 |
Number of CDKL3 related diseases |
0 |
All kinase in this family
CDKL3
Allelic Variants |
Disease Description |
Involved kinases (This family) |
Inhibitor of Involved Kinases |
Search Disease |
n/a | Tuberculosis | AKT2, AKT3, CAMK2B, CAMK2D, CAMK2G, MAPK13, PLK3 | 11 | Link | n/a | Epstein-Barr virus infection | AKT2, AKT3, CDK2, CSNK2A1, CSNK2A2, MAPK13 | 12 | Link | n/a | Measles | AKT2, AKT3, CDK2, CSNK2A1, CSNK2A2 | 12 | Link | n/a | Influenza A | AKT2, AKT3, MAPK13, PRKCA, PRKCB | 58 | Link | | Prostate cancer | AKT2, AKT3, CDK2, CHEK2 | 13 | Link | | Leukemia | AKT2, AKT3, PIM1, PIM2 | 12 | Link | n/a | Hepatitis C | AKT2, AKT3, MAPK13 | 7 | Link | | Lung cancer | AKT2, AKT3, CDK2 | 12 | Link | n/a | Herpes simplex infection | CDK2, CSNK2A1, CSNK2A2 | 12 | Link | n/a | Chagas disease | AKT2, AKT3, MAPK13 | 7 | Link | n/a | Toxoplasmosis | AKT2, AKT3, MAPK13 | 7 | Link | | Mental retardation | CASK, PAK3, RPS6KA3 | 10 | Link | | Diabetes mellitus | AKT2, PRKCE | 11 | Link | n/a | Epithelial cell signaling in Helicobacter pylori infection | MAPK13, PAK1 | 10 | Link | | Melanoma | AKT2, AKT3 | 7 | Link | n/a | Leishmaniasis | MAPK13, PRKCB | 10 | Link | n/a | Amoebiasis | PRKCA, PRKCB | 55 | Link | n/a | African trypanosomiasis | PRKCA, PRKCB | 55 | Link | n/a | Vibrio cholerae infection | PRKCA, PRKCB | 55 | Link | n/a | Non-syndromic X-linked mental retardation | PAK3, RPS6KA3 | 10 | Link | n/a | Cocaine addiction | CDK5 | 5 | Link | n/a | Familial partial lipodystrophy | AKT2 | 7 | Link | n/a | Alcoholism | CAMKK2 | 11 | Link | n/a | FG syndrome | CASK | 1 | Link | n/a | Prader-Willi and Angelman syndromes | CDKL5 | 1 | Link | | Hypoinsulinemic hypoglycemia | AKT2 | 7 | Link | | Colon cancer | AURKA | 8 | Link | n/a | Epileptic encephalopathy | CDKL5 | 1 | Link | n/a | Early infantile epileptic encephalopathy | CDKL5 | 1 | Link | n/a | Cirrhosis due to liver phosphorylase kinase deficiency | PHKG2 | 9 | Link | n/a | Glycogen storage diseases | PHKG2 | 9 | Link | n/a | Nephronophthisis | NEK8 | 1 | Link | | Glycogen storage disease | PHKG2 | 9 | Link | n/a | Pathogenic Escherichia coli infection | PRKCA | 55 | Link | n/a | Basal cell carcinoma | STK36 | 3 | Link | n/a | Coffin-Lowry syndrome | RPS6KA3 | 8 | Link | n/a | Cerebral infarction | PRKCH | 12 | Link | n/a | Pituitary tumor | PRKCA | 55 | Link | n/a | Nephronophthisis-medullary cystic kidney disease | NEK8 | 1 | Link | n/a | Pertussis | MAPK13 | 1 | Link | | Breast cancer | CHEK2 | 5 | Link | | Li-Fraumeni syndrome | CHEK2 | 5 | Link | | Ovarian cancer | AKT2 | 7 | Link | n/a | Angelman syndrome-like | CDKL5 | 1 | Link | | Osteosarcoma | CHEK2 | 5 | Link | n/a | Bladder cancer | DAPK1 | 8 | Link | n/a | Salmonella infection | MAPK13 | 1 | Link | n/a | Shigellosis | MAPK13 | 1 | Link | n/a | Amyotrophic lateral sclerosis | MAPK13 | 1 | Link | n/a | Endocrine-cerebroosteodysplasia | ICK | 2 | Link |
|